The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sabra Health Care REIT Inc
F:SBC
|
US |
|
J
|
JCDecaux SE
F:DCS
|
FR |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
T
|
Tirathai PCL
SET:TRT
|
TH |
|
C
|
Chow Tai Fook Jewellery Group Ltd
XMUN:1CT
|
HK |
|
Singapore Post Ltd
F:SGR
|
SG |
|
A
|
Anglogold Ashanti PLC
JSE:ANG
|
US |
|
Nu Holdings Ltd.
NYSE:NU
|
BR |
|
Interparfums Inc
NASDAQ:IPAR
|
US |
|
Carlo Gavazzi Holding AG
SIX:GAV
|
CH |
|
G
|
Global Cannabis Applications Corp
F:2FA
|
CA |
|
R
|
Retailors Ltd
TASE:RTLS
|
IL |
|
A
|
Anheuser-Busch Inbev SA
F:ITKA
|
BE |
|
Ryman Healthcare Ltd
ASX:RYM
|
NZ |
|
A
|
Adler Group SA
F:ADJ
|
LU |
|
Alexander's Inc
F:AXE
|
US |
|
N
|
Netcall PLC
F:NEW
|
UK |
|
T
|
Target Corp
F:DYH
|
US |
|
W
|
Williams-Sonoma Inc
XMUN:WM1
|
US |
|
A
|
Aizawa Securities Group Co Ltd
F:MK0
|
JP |
|
P
|
Polaris Inc
F:PL6
|
US |
|
IPH Ltd
ASX:IPH
|
AU |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
Sabra Health Care REIT Inc (SBC)’s 12-month stock price forecast through October 2027 has a consensus target of €19.71, implying 13% upside. The forecast is based on price targets from 17 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SBC is 19.71 EUR with a low forecast of 16.86 EUR and a high forecast of 23.06 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more